SK

Sudheer Kumar Nekkanti

Active Director Designated Partner DIN 07093735
DIN 07093735 First appointment May 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudheer Kumar Nekkanti

Data last updated:

Sudheer Kumar Nekkanti is a Designated Partner at Ecleaf Pharmaceuticals Llp (since 2015). The company operates in Pharma.

DIN 07093735
Primary Designation Designated Partner
Industry Pharma
First Appointment 15 May 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 May 20152015Active

Board colleagues of Sudheer Kumar Nekkanti

NameDINCompanyDesignation
Nagendra Babu Somarowthu07093728Ecleaf Pharmaceuticals LlpDesignated Partner
Paturi Thrinadh07093744Ecleaf Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Ecleaf Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Sudheer Kumar Nekkanti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudheer Kumar Nekkanti

Sudheer Kumar Nekkanti currently holds 1 directorship: Ecleaf Pharmaceuticals Llp (Designated Partner, since 15 May 2015).

Sudheer Kumar Nekkanti was first appointed on 15 May 2015 as Designated Partner at Ecleaf Pharmaceuticals Llp.

The current boards of Sudheer Kumar Nekkanti's companies include Nagendra Babu Somarowthu (Ecleaf Pharmaceuticals Llp), Paturi Thrinadh (Ecleaf Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available